Abstract
Upper gastrointestinal bleeding remains a major clinical problem in medicine with an estimated hospital admission rate of 50–150 per 100,000 population for actue upper gastrointestinal bleeding (1, 2). In 1983 it is a sobering fact that there is not always an effective therapeutic modality for upper gastrointestinal bleeding. The treatment is still fraught with futility. The mortality has remained between 10–15% for 40 years, despite advances in resuscitation and in the care of critically ill patients in intensive care units; and despite the ready availability of fiberoptic endoscopy, a modality which many thought would improve treatment and prognosis by early specific diagnosis. Finally, with the advent of effective anti-secretory histamine H2 receptor antagonists it has been hoped that there would be a significant reduction in morbidity and mortality in upper gastrointestinal bleeding. However, neither cimetidine or other currently available antisecretory drugs effectively control upper gastrointestinal bleeding. (23) The principles in management of upper gastrointestinal bleeding should continue to be a team approach, covering:
-
1.
Resuscitation
-
2.
Specific diagnosis (endoscopy, radionuclide Tc99, angiography)
-
3.
Specific effective therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schiller DFR, Truelove SC, Williams DG. Hematemesis and melena with special reference to factors influencing the outcome. Brit. Med. J. 1970; 2: 7–14.
Morgan AG, McAdam WAF, Walmsley GL, et al. Clinical findings, early endoscopy, and multivariate analysis in patients bleeding from the upper gastrointestinal tract. Brit. Med. J. 1977; 2: 237–240.
Allan R, Dykes P. A study of the factors influencing mortality rates from gastrointestinal hemorrhage. Quart. J. Med. 1976; 45: 550–553.
Silverstein FE, Gilbert DA, Tedesco FJ, et al. The National ASGE Survey on Upper Gastrointestinal Bleeding. I. Study design and baseline data. Gastrointestinal Endosc. 1981; 27: 73–79.
Silverstein FE, Gilbert DA, Tedesco FJ, et al. The National ASGE Survey on Upper Gastrointestinal Bleeding. II. Clinical prognostic factors. Gastrointestinal Endosc. 1981; 27: 80–93.
Katon RM, Smith FW. Panendoscopy in the early diagnosis of acute upper gastrointestinal bleeding. Gastroenterology 1975; 65: 728–734.
Hoare AM. Comparative study between endoscopy and radiology in acute gastrointestinal haemorrhage. Brit. Med. J. 1975; 127–30.
Silverstein FE, Gilbert DA, Tedesco FJ, et al. The National ASGE Survey on Upper Gastrointestinal Bleeding. III. Endoscopy in upper gastrointestinal bleeding. Gastrointestinal Endosc. 1981; 27: 94–102.
Moody FG, Cheung LY, et al. Stress and the acute gastric mucosal lesion. Am. J. Dig. Dis. 1976; 21: 148–154.
Skillman, II, Bushness LS, Goldman H, et al. Respiratory failure, hypotension, sepsis and jaundice: a clinical syndrome associated with lethal hemorrhage from acute stress ulceration of the stomach. Am. J. Surg. 1969; 117: 523–5330.
Lucas GE, Sugawa C, Riddle J, et al. Natural history and surgical dilemma of “Stress” gastric bleeding. Arch. Surg. 1971; 102: 266–273
Menguy R, Desbaillets L, Masters YF. Mechanisms of stress ulcer: influence of hypovolemic shock on energy metabolism in the gastric mucosa. Gastroenterology 1974; 66: 46–55.
Kawarada Y, Lambek J, Matsumoto T. Pathophysiology of stress ulcer and its prevention. II. Prostaglandin E1 and microcircu- latory responses in stress ulcer. Am. J. Surg. 9175; 129 : 217–222.
Preibe JH, Skillman JJ, Bushness LS, et al. Antacid versus cimetidine in preventing acute gastrointestinal bleeding: A randomized trial of 75 critically ill patents. N. Engl. J. Med. 1980; 302: 426–430.
Stothert JC, Sminowitz DZ, Dellinger EP, et al. Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann. Surg. 1980; 192 (2): 169–174.
Welch R, Douglas A, Cohen S, et al. Effect of cimetidine on upper gastrointestinal hemorrhage. Gastroenterology 1981; 80: 1313 (abstract).
Athansoulis CA, Baum S, Waltman AC, et al. Control of acute gastric mucosal hemorrhage intra-arterial infusion of posterior pituitary extract. N. Engl. J. Med. 1974; 290: 597–603.
Conn HO, Ramsby GR, Storer EH, et al. Intra-arterial vasopressin in the treatment of upper gastrointestinal hemorrhage: A prospective, controlled clinical trial. Gastroenterology 1975; 68: 211–221.
Robert A. Prostaglandins and the gastrointestinal tract, in Physiology of the GI tract. Physiology of the GI tract. Editect by Leonard R Johnson. Raven Press, New York, Chapter 57 1981: 1407–1434.
Waller SL. Progress report: Prostaglandins and the gastrointestinal tract. GUT 1973; 14: 402–417.
Carmichael HA, Nelson LM, et al. The effect of the synthetic prostaglandin analogue 15(R)–15 Methyl PGE2 on gastric mucosal hemorrhage induced in rats by taurocholic acid and hydrochloric acid. Am. J. Dig. Dis. 1977; 22: 411–414.
Charmichael HL, Nelson LM, Russel RI. Cimetidine and prostaglandin: Evidence for different modes of action on the rat gastric mucosa. Gastroenterology 1978; 74: 1229–32.
Wolling A, Code CF, Dousa TP. Interaction of prostaglandins and histamine with enzymes of cyclic AMP. Metabolism from guinea pig gastric mucosa. J. Clin. Invest. 1976; 571548–1553.
Dazani EZ, Callison DA, Bertermann BE. Effects of E prostaglandins on canine gastric potential difference. Am. J. Dig. Dis. 1978; 23: 436–442.
Guth PH, Aures D, Paulsen G. Topical aspirin plus HCl gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine and probanhtin. Gastroenterology 1979; 76: 88–93.
Garner A, Heylings JR. Stimulation of alkaline secretion in amphibian isolated gastric mucosa by 16, 16 Dimethyl PGE2 and \( {\text{PG}}{{\text{R}}_2}_a \bullet \) . Gastroenterology 1979; 76: 497–503.
Robert A, Nezamis Je, Lancaster C, et al. Cytoprotection by prostaglandins in rats. Gastroenterology 1979; 77 433–443.
Robert AR, Schultz JR, Nezamis JE, et al. Gastric antisecretory and antiulcer properties of PGE2, 15-Methyl PGE2 and 16, 16 Dimethyl PGE2. Gastroenterology 1976; 70: 359–370.
Bolton J, Palmer D, Cohen MM. Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Am. J. Dig. Dis. 1978; 23: 359–364.
Robert A, Nezamis JE, Lancaster C, et al. Gastric cytoprotective property of prostaglandins. Gastroenterology 1977; 72: 1121 (abstract).
Robert A, Lancaster C, Nezamis JE, Hanchar AJ. Cytoprotective prostaglandins exogenous or endogenous can maintain gastric secretory function. Gastroenterology 1978; 74: 1086 (abstract).
Chaundhury TK, Jacobson ED. Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 1978; 74: 56–63.
Konturek SJ, Piastucki I, Brzozowski T, et al. Role of prostaglandins in the formation of aspirin induced gastric ulcers. Gastroenterology 1981; 80: 4–9.
Konturek SJ, Robert AR, et al. Comparison of Methyl-lated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. Gastroenterology 1976; 70: 683–687.
Johansson C, Kollberg B, Nordemar R, et al. Protective effect of prostaglandin E2 in the GI tract during indomethacin treatment of rheymatic diseases. Gastroenterology 1980; 78: 479–483.
Tarnawski A, Stachura J, Ivey KJ, et al. Protection by prostaglandin against ethanol induced gastric mucosal damage in man. An endoscopic and histologic assessment. Gastroenterology 1981; 80: 1300 (abstract).
Gilbert DA, Feld AD, Silverstein FE, et al. 15(R)–15 methyl PGE2 cytoprotection in aspirin-induced gastric mucosal injury - an endoscopic study. Gastroenterology 1981; 80: 1155 (abstract).
Cohen MK. Mucosal cytoprotection by prostaglandin E2 (letter). Lancet 1978; 2: 1253–1254.
Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761–767.
Miller T, Jacobson ED. Progress report: Gastrointestinal cytoprotection by prostaglandins. GUT 1979; 20: 75–87.
Weiss JB, Peskin GW, Isenbert JT. Treatment of hemorrhage gastritis with 15(R)-15 Methyl prostaglandin E2. Report of a case. Gastroenterology 1982; 82: 558–60.
Bright-Asare P, Kauffman GL. 16–16 Dimethyl prostaglandin E2 (DMPGE2) reduces 5 fluorouracil (5FU) induced gastric mucosal injury in dog. Gastroenterology May 1982; Part 2.
Giannikopoulos I, Bright-Asare P, et al. Use of 15(R)–15 Methyl prostaglandin E2 (15(R)–15 MEPGE2) for the treatment of massive upper gastrointestinal bleeding in a critically ill patient. American Society for Gastrointestinal Endoscopy. Gastrointestinal Endosc. May 1982; Suppl: 3.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Bright-Asare, P. (1983). Endoscopic and Pharmacologic Therapy of Upper Gastrointestinal Bleeding’. Laser vs. Pharmacotherapy vs. Autacid. In: Fleischer, D., Jensen, D., Bright-Asare, P. (eds) Therapeutic Laser Endoscopy in Gastrointestinal Disease. Developments in Gastroenterology, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6723-6_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-6723-6_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-6725-0
Online ISBN: 978-94-009-6723-6
eBook Packages: Springer Book Archive